Busca un médico

Peter J. Tebben, M.D.

  1. Pediatric Endocrinologist
Solicite una Consulta

Publicaciones

  1. Zhu Z, Bo-Ran Ho B, Chen A, Amrhein J, Apetrei A, Carpenter TO, Lazaretti-Castro M, Colazo JM, McCrystal Dahir K, Gessner M, Gurevich E, Heier CA, Simmons JH, Hunley TE, Hoppe B, Jacobsen C, Kouri A, Ma N, Majumdar S, Molin A, Nokoff N, Ott SM, Pena HG, Santos F, Tebben P, Topor LS, Deng Y, Bergwitz C. An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH). Kidney Int. 2024 May; 105 (5):1058-1076 Epub 2024 Feb 15
    View PubMed
  2. Pinto E Vairo F, Kemppainen JL, Vitek CRR, Whalen DA, Kolbert KJ, Sikkink KJ, Kroc SA, Kruisselbrink T, Shupe GF, Knudson AK, Burke EM, Loftus EC, Bandel LA, Prochnow CA, Mulvihill LA, Thomas B, Gable DM, Graddy CB, Garzon GGM, Ekpoh IU, Porquera EMC, Fervenza FC, Hogan MC, El Ters M, Warrington KJ, Davis JM 3rd, Koster MJ, Orandi AB, Basiaga ML, Vella A, Kumar S, Creo AL, Lteif AN, Pittock ST, Tebben PJ, Abate EG, Joshi AY, Ristagno EH, Patnaik MS, Schimmenti LA, Dhamija R, Sabrowsky SM, Wierenga KJ, Keddis MT, Samadder NJJ, Presutti RJ, Robinson SI, Stephens MC, Roberts LR, Faubion WA Jr, Driscoll SW, Wong-Kisiel LC, Selcen D, Flanagan EP, Ramanan VK, Jackson LM, Mauermann ML, Ortega VE, Anderson SA, Aoudia SL, Klee EW, McAllister TM, Lazaridis KN. Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD). J Transl Med. 2024 Apr 30; 22 (1):400
    View PubMed
  3. Salama M, Tebben PJ, Al Nofal A. An infant developing hypercalcemia and hypophosphatemia due to the use of exclusively almond milk. J Pediatr Endocrinol Metab. 2024 Apr 25; 37 (4):375-379 Epub 2024 Feb 29
    View PubMed
  4. Mohan S, Sheehan M, Tebben P, Wermers R. Efficacy of Oral Cinacalcet in Non-PTH Nonmalignant Hypercalcemia from Excess 1,25-Dihydroxyvitamin D. JCEM Case Rep. 2024 Mar; 2 (3):luae022 Epub 2024 Mar 12
    View PubMed
  5. Shariq OA, Abrantes VB, Lu LY, Tebben PJ, Foster TM, Dy BM, Lyden ML, Young WF, McKenzie TJ. Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: Impact of genotype and surgical approach on long-term postoperative outcomes. Surgery. 2024 Jan; 175 (1):8-16 Epub 2023 Oct 25
    View PubMed
  6. Pinto E Vairo F, Kemppainen JL, Vitek CRR, Whalen DA, Kolbert KJ, Sikkink KJ, Kroc SA, Kruisselbrink T, Shupe GF, Knudson AK, Burke EM, Loftus EC, Bandel LA, Prochnow CA, Mulvihill LA, Thomas B, Gable DM, Graddy CB, Garzon GGM, Ekpoh IU, Porquera EMC, Fervenza FC, Hogan MC, El Ters M, Warrington KJ, Davis JM 3rd, Koster MJ, Orandi AB, Basiaga ML, Vella A, Kumar S, Creo AL, Lteif AN, Pittock ST, Tebben PJ, Abate EG, Joshi AY, Ristagno EH, Patnaik MS, Schimmenti LA, Dhamija R, Sabrowsky SM, Wierenga KJ, Keddis MT, Samadder NJJ, Presutti RJ, Robinson SI, Stephens MC, Roberts LR, Faubion WA Jr, Driscoll SW, Wong-Kisiel LC, Selcen D, Flanagan EP, Ramanan VK, Jackson LM, Mauermann ML, Ortega VE, Anderson SA, Aoudia SL, Klee EW, McAllister TM, Lazaridis KN. Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD). J Transl Med. 2023 Jun 23; 21(1):410.
    View PubMed
  7. Szabo Yamashita T, Gudmundsdottir H, Foster TR, Lyden ML, Dy BM, Tebben PJ, McKenzie T. Pediatric primary hyperparathyroidism: Surgical pathology and long-term outcomes in sporadic and familial cases. Am J Surg. 2023 Apr; 225 (4):699-702 Epub 2022 Oct 17
    View PubMed
  8. Tebben PJ. Hypophosphatemia: A Practical Guide to Evaluation and Management. Endocr Pract. 2022 Oct; 28 (10):1091-1099 Epub 2022 Aug 06
    View PubMed
  9. Dahl AR, Armellino AL, Tran CL, Tebben PJ. Skimmed breast milk for treatment of hypertriglyceridemia in an infant with congenital nephrotic syndrome. Nutr Clin Pract. 2022 Apr; 37 (2):383-387 Epub 2021 Sept 06
    View PubMed
  10. Milioto A, Reyes M, Hanna P, Kiuchi Z, Turan S, Zeve D, Agarwal C, Grigelioniene G, Chen A, Mericq V, Frangos M, Ten S, Mantovani G, Salusky IB, Tebben P, Juppner H. Lack of GNAS Remethylation During Oogenesis May Be a Cause of Sporadic Pseudohypoparathyroidism Type Ib. J Clin Endocrinol Metab. 2022 Mar 24; 107 (4):e1610-e1619
    View PubMed
  11. Hanna C, Potretzke TA, Chedid M, Rangel LJ, Arroyo J, Zubidat D, Tebben PJ, Cogal AG, Torres VE, Harris PC, Sas DJ, Lieske JC, Milliner DS, Chebib FT. Kidney Cysts in Hypophosphatemic Rickets With Hypercalciuria: A Case Series. Kidney Med. 2022 Mar; 4 (3):100419 Epub 2022 Jan 24
    View PubMed
  12. Wang Z, Joshi A, Leopold K, Jackson S, Christensen S, Nayfeh T, Mohammed K, Creo A, Tebben P, Kumar S. Association of vitamin D deficiency with COVID-19 infection severity: Systematic review and meta-analysis. Clin Endocrinol (Oxf). 2022 Mar; 96 (3):281-287 Epub 2021 July 12
    View PubMed
  13. Kiuchi Z, Reyes M, Hanna P, Sharma A, DeClue T, Olney RC, Tebben P, Juppner H. Progression of PTH Resistance in Autosomal Dominant Pseudohypoparathyroidism Type Ib Due to Maternal STX16 Deletions. J Clin Endocrinol Metab. 2022 Jan 18; 107 (2):e681-e687
    View PubMed
  14. Azer SM, Vaughan LE, Tebben PJ, Sas DJ. 24-Hydroxylase Deficiency Due to CYP24A1 Sequence Variants: Comparison With Other Vitamin D-mediated Hypercalcemia Disorders. J Endocr Soc. 2021 Sep 1; 5 (9):bvab119 Epub 2021 July 02
    View PubMed
  15. Hanna C, Potretzke TA, Cogal AG, Mkhaimer YG, Tebben PJ, Torres VE, Lieske JC, Harris PC, Sas DJ, Milliner DS, Chebib FT. High Prevalence of Kidney Cysts in Patients With CYP24A1 Deficiency. Kidney Int Rep. 2021 Jul; 6 (7):1895-1903 Epub 2021 May 12
    View PubMed
  16. Zavatta G, Tebben PJ, McCollough CH, Yu L, Vrieze T, Clarke BL. Basal Ganglia Calcification Is Associated With Local and Systemic Metabolic Mechanisms in Adult Hypoparathyroidism. J Clin Endocrinol Metab. 2021 Jun 16; 106 (7):1900-1917
    View PubMed
  17. Gupta N, Gregory SW, Deyle DR, Tebben PJ. Three Patient Kindred with a Novel Phenotype of Osteogenesis Imperfecta due to a COL1A1 Variant J Clin Res Pediatr Endocrinol. 2021 Jun 2; 13 (2):218-224 Epub 2020 June 10
    View PubMed
  18. Qureshi MY, Patterson MC, Clark V, Johnson JN, Moutvic MA, Driscoll SW, Kemppainen JL, Huston J 3rd, Anderson JR, Badley AD, Tebben PJ, Wackel P, Oglesbee D, Glockner J, Schreiner G, Dugar S, Touchette JC, Gavrilova RH. Safety and efficacy of (+)-epicatechin in subjects with Friedreich's ataxia: A phase II, open-label, prospective study. J Inherit Metab Dis. 2021 Mar; 44 (2):502-514 Epub 2020 Aug 31
    View PubMed
  19. Hawkes CP, Roy SM, Dekelbab B, Frazier B, Grover M, Haidet J, Listman J, Madsen S, Roan M, Rodd C, Sopher A, Tebben P, Levine MA. Hypercalcemia in Children Using the Ketogenic Diet: A Multicenter Study. J Clin Endocrinol Metab. 2021 Jan 23; 106 (2):e485-e495
    View PubMed
  20. Christensen S, Tebben PJ, Sas D, Creo AL. Variable Clinical Presentation of Children with Hereditary Hypophosphatemic Rickets with Hypercalciuria: A Case Series and Review of the Literature. Horm Res Paediatr 2021; 94 (9-10):374-389 Epub 2021 Oct 19
    View PubMed
  21. Muthusamy K, Hanna C, Johnson DR, Cramer CH, Tebben PJ, Libi SE, Poling GL, Lanpher BC, Morava E, Schimmenti LA. Growth hormone deficiency in a child with branchio-oto-renal spectrum disorder: Clinical evidence of EYA1 in pituitary development and a recommendation for pituitary function surveillance. Am J Med Genet A. 2021 Jan; 185 (1):261-266 Epub 2020 Oct 24
    View PubMed
  22. Eswarakumar AS, Ma NS, Ward LM, Backeljauw P, Wasserman H, Weber DR, DiMeglio LA, Imel EA, Gagne J, Cody D, Zimakas P, Topor LS, Agrawal S, Calabria A, Tebben P, Faircloth RS, Gordon R, Casey L, Carpenter TO. Long-Term Follow-up of Hypophosphatemic Bone Disease Associated With Elemental Formula Use: Sustained Correction of Bone Disease After Formula Change or Phosphate Supplementation. Clin Pediatr (Phila). 2020 Oct; 59 (12):1080-1085 Epub 2020 July 15
    View PubMed
  23. Muthusamy K, Macke EL, Klee EW, Tebben PJ, Hand JL, Hasadsri L, Marcou CA, Schimmenti LA. Congenital ichthyosis in Prader-Willi syndrome associated with maternal chromosome 15 uniparental disomy: Case report and review of autosomal recessive conditions unmasked by UPD. Am J Med Genet A. 2020 Oct; 182 (10):2442-2449 Epub 2020 Aug 20
    View PubMed
  24. Muthusamy K, Macke E, Klee EW, Tebben PJ, Hand JL. Congenital Ichthyosis American Journal of Medical Genetics. 2020.
  25. Wadams HD, Gupta N, Novotny P, Tebben PJ. Onset of pituitary hormone deficiencies in optic nerve hypoplasia: a temporal trend analysis of 32 children at Mayo Clinic. J Pediatr Endocrinol Metab. 2020 Jan 28; 33 (1):139-145
    View PubMed
  26. Weber DR, Boyce A, Gordon C, Hogler W, Kecskemethy HH, Misra M, Swolin-Eide D, Tebben P, Ward LM, Wasserman H, Shuhart C, Zemel BS. The Utility of DXA Assessment at the Forearm, Proximal Femur, and Lateral Distal Femur, and Vertebral Fracture Assessment in the Pediatric Population: 2019 ISCD Official Position. J Clin Densitom. 2019 Oct - Dec; 22 (4):567-589 Epub 2019 July 10
    View PubMed
  27. Creo A, Anderson H, Cannon B, Lteif A, Kumar S, Tebben P, Iqbal AM, Ramakrishna A, Pittock S. Patterns of amiodarone-induced thyroid dysfunction in infants and children. Heart Rhythm. 2019 Sep; 16 (9):1436-1442 Epub 2019 Mar 21
    View PubMed
  28. Thacher TD, Pettifor JM, Tebben PJ, Creo AL, Skrinar A, Mao M, Chen CY, Chang T, San Martin J, Carpenter TO. Rickets severity predicts clinical outcomes in children with X-linked hypophosphatemia: Utility of the radiographic Rickets Severity Score. Bone. 2019 May; 122:76-81 Epub 2019 Feb 14
    View PubMed
  29. Gupta N, Lteif A, Creo A, Iqbal AM, Pittock S, Tebben PJ, Hansen J, Heyrman M, Spee R, Scanlan-Hanson L, Kumar S. Improved utilization of waist-to-height ratio in cardiometabolic risk counselling in children: Application of DMAIC strategy. J Eval Clin Pract. 2019 Apr; 25 (2):300-305 Epub 2018 Oct 31
    View PubMed
  30. Boland JM, Tebben PJ, Folpe AL. Phosphaturic mesenchymal tumors: what an endocrinologist should know. J Endocrinol Invest. 2018 Oct; 41 (10):1173-1184 Epub 2018 Feb 14
    View PubMed
  31. Dahl AR, Iqbal AM, Lteif AN, Pittock ST, Tebben PJ, Kumar S. Mild subclinical hypothyroidism is associated with paediatric dyslipidaemia. Clin Endocrinol (Oxf). 2018 Sep; 89 (3):330-335 Epub 2018 June 21
    View PubMed
  32. Hana Lo, Theresa Wampler Muskardin , Peter J Tebben . BLAU SYNDROME: AN UNUSUAL CAUSE OF HYPERCALCEMIA IN A CHILD AACE Clinical Case Reports. 2018; 4(4):e278-e281.
  33. Creo AL, Epp LM, Buchholtz JA, Tebben PJ. Prevalence of Metabolic Bone Disease in Tube-Fed Children Receiving Elemental Formula. Horm Res Paediatr. 2018; 90 (5):291-298 Epub 2018 Nov 29
    View PubMed
  34. Creo AL, Tebben PJ, Fischer PR, Thacher TD, Pittock ST. Cardiac Arrest in a Vitamin D-Deficient Infant. Glob Pediatr Health. 2018; 5:2333794X18765064 Epub 2018 Mar 20
    View PubMed
  35. Sakka S, Gafni RI, Davies JH, Clarke B, Tebben P, Samuels M, Saraff V, Klaushofer K, Fratzl-Zelman N, Roschger P, Rauch F, Hogler W. Bone Structural Characteristics and Response to Bisphosphonate Treatment in Children With Hajdu-Cheney Syndrome. J Clin Endocrinol Metab. 2017 Nov 1; 102 (11):4163-4172
    View PubMed
  36. Kumar A, Wermers RA, Tebben PJ. Iron replacement as a therapeutic approach for renal phosphate wasting with associated iron deficiency AACE Clinical Case Reports.2017;3:(3)e260-e263.
  37. Gonzalez Ballesteros LF, Ma NS, Gordon RJ, Ward L, Backeljauw P, Wasserman H, Weber DR, DiMeglio LA, Gagne J, Stein R, Cody D, Simmons K, Zimakas P, Topor LS, Agrawal S, Calabria A, Tebben P, Faircloth R, Imel EA, Casey L, Carpenter TO. Unexpected widespread hypophosphatemia and bone disease associated with elemental formula use in infants and children. Bone. 2017 Apr; 97:287-292 Epub 2017 Feb 04
    View PubMed
  38. Tebben PJ, Singh RJ, Kumar R. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment. Endocr Rev. 2016 Oct; 37 (5):521-547 Epub 2016 Sept 02
    View PubMed
  39. O'Keeffe DT, Tebben PJ, Kumar R, Singh RJ, Wu Y, Wermers RA. Clinical and biochemical phenotypes of adults with monoallelic and biallelic CYP24A1 mutations: evidence of gene dose effect. Osteoporos Int. 2016 Oct; 27 (10):3121-5 Epub 2016 Apr 29
    View PubMed
  40. Trivedi S, Al-Nofal A, Kumar S, Tripathi S, Kahoud RJ, Tebben PJ. Severe non-infective systemic inflammatory response syndrome, shock, and end-organ dysfunction after zoledronic acid administration in a child. Osteoporos Int. 2016 Jul; 27 (7):2379-2382 Epub 2016 Feb 18
    View PubMed
  41. Uzodi AS, Tebben PJ, Boyce TG. Bone Pain in a 4-year-old Boy with Chronic Granulomatous Disease and History of Aspergillus pneumonia. Pediatr Infect Dis J. 2016 Apr; 35: (4)464-5, 469.
    View PubMed
  42. Al Nofal AA, Altayar O, BenKhadra K, Qasim Agha OQ, Asi N, Nabhan M, Prokop LJ, Tebben P, Murad MH. Bone turnover markers in Paget's disease of the bone: A Systematic review and meta-analysis. Osteoporos Int. 2015 Jul; 26(7):1875-91. Epub 2015 Jun 03.
    View PubMed
  43. James HA, Griebeler ML, Tebben PJ. 70-year-old woman with buttock pain and hypercalcemia. Mayo Clin Proc. 2014 Sep; 89(9):1313-7.
    View PubMed
  44. Kundel A, Thompson GB, Richards ML, Qiu LX, Cai Y, Schwenk FW, Lteif AN, Pittock ST, Kumar S, Tebben PJ, Hay ID, Grant CS. Pediatric endocrine surgery: a 20-year experience at the Mayo Clinic. J Clin Endocrinol Metab. 2014 Feb; 99 (2):399-406 Epub 2013 Dec 11
    View PubMed
  45. Javed A, Tebben PJ, Fischer PR, Lteif AN. Female athlete triad and its components: toward improved screening and management. Mayo Clin Proc. 2013 Sep; 88(9):996-1009.
    View PubMed
  46. Gardner KH, Shon W, Folpe AL, Wieland CN, Tebben PJ, Baum CL. Tumor-induced osteomalacia resulting from primary cutaneous phosphaturic mesenchymal tumor: a case and review of the medical literature. J Cutan Pathol. 2013 Sep; 40(9):780-4; quiz 779.
    View PubMed
  47. Berkseth KE, Tebben PJ, Drake MT, Hefferan TE, Jewison DE, Wermers RA. Clinical spectrum of hypophosphatasia diagnosed in adults. Bone. 2013 May; 54(1):21-7. Epub 2013 Jan 22.
    View PubMed
  48. Thacher TD, Fischer PR, Tebben PJ, Singh RJ, Cha SS, Maxson JA, Yawn BP. Increasing incidence of nutritional rickets: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc. 2013 Feb; 88 (2):176-83
    View PubMed
  49. Kumar R, Tebben PJ, Thompson JR. Vitamin D and the kidney. Arch Biochem Biophys. 2012 Jul 1; 523 (1):77-86 Epub 2012 Mar 15
    View PubMed
  50. Tebben PJ, Milliner DS, Horst RL, Harris PC, Singh RJ, Wu Y, Foreman JW, Chelminski PR, Kumar R. Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy. J Clin Endocrinol Metab. 2012 Mar; 97(3):E423-7. Epub 2012 Feb 15.
    View PubMed
  51. Dy BM, Vazquez B, Tebben PJ, Kumar S, Thompson GB. Severe hypercalcemia due to primary hyperparathyroidism with MEN 2A. World J Endocr Surg.2010;2:(3):131-3.
  52. Kirmani S, Tebben PJ, Lteif AN, Gordon D, Clarke BL, Hefferan TE, Yaszemski MJ, McGrann PS, Lindor NM, Ellison JW. Germline TGF-beta receptor mutations and skeletal fragility: a report on two patients with Loeys-Dietz syndrome. Am J Med Genet A. 2010 Apr; 152A (4):1016-9
    View PubMed
  53. Ellison J, Tebben P. Novel human pathological mutations. Gene symbol: PHEX. Disease: rickets, hypophosphataemic. Hum Genet. 2009 Apr; 125(3):339.
    View PubMed
  54. Tebben PJ, Atkinson JL, Scheithauer BW, Erickson D. Granulomatous adenohypophysitis after interferon and ribavirin therapy. Endocr Pract. 2007 Mar-Apr; 13 (2):169-75
    View PubMed
  55. Hodgson SF, Clarke BL, Tebben PJ, Mullan BP, Cooney WP 3rd, Shives TC. Oncogenic osteomalacia: localization of underlying peripheral mesenchymal tumors with use of Tc 99m sestamibi scintigraphy. Endocr Pract. 2006 Jan-Feb; 12 (1):35-42
    View PubMed
  56. Berndt TJ, Bielesz B, Craig TA, Tebben PJ, Bacic D, Wagner CA, O'Brien S, Schiavi S, Biber J, Murer H, Kumar R. Secreted frizzled-related protein-4 reduces sodium-phosphate co-transporter abundance and activity in proximal tubule cells. Pflugers Arch. 2006 Jan; 451 (4):579-87 Epub 2005 Sept 09
    View PubMed
  57. Tebben PJ, Kalli KR, Cliby WA, Hartmann LC, Grande JP, Singh RJ, Kumar R. Elevated fibroblast growth factor 23 in women with malignant ovarian tumors. Mayo Clin Proc. 2005 Jun; 80 (6):745-51
    View PubMed
  58. Tebben PJ, Singh RJ, Clarke BL, Kumar R. Fibroblast growth factor 23, parathyroid hormone, and 1alpha,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism. Mayo Clin Proc. 2004 Dec; 79 (12):1508-13
    View PubMed
  59. Tebben PJ, Pope TW, Hinson G, Batnitzky S, Wetzel LH, DePaolis DC, Munns S, Wilkinson SB, Gordon MA. Three-dimensional computerized reconstruction. Illustration of incremental articular cartilage thinning. Invest Radiol. 1997 Aug; 32(8):475-84.
    View PubMed
PST-20224093